NCT00857532View on ClinicalTrials.gov

Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Parkinson's Disease
Interventions
DRUG

florbetapir F 18

10 millicurie (mCi) (370 MBq) florbetapir F 18 Injection

Trial Locations (1)

19104

Research Site, Philadelphia

Sponsors
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Avid Radiopharmaceuticals

INDUSTRY